KRISTI NISSLEY: Open Payments
NPI 1811225717 · MITCHELL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 58 payments from 16 companies in 2025. Trend: 2023 $662 · 2024 $640 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $210 |
| ABBVIE INC. | 15 | $205 |
| AstraZeneca Pharmaceuticals LP | 4 | $157 |
| Otsuka America Pharmaceutical, Inc. | 7 | $117 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Lilly USA, LLC | 2 | $29 |
| Biogen, Inc. | 1 | $27 |
Products named: CAPLYTA, VRAYLAR, REXULTI, AIRSUPRA, Auvelity, NURTEC ODT, VOQUEZNA, Ozempic.
Industry payments across IN — which companies pay providers there.
